EDGAR Filing Documents for 0001144204-15-042136

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001144204-15-042136

Filing Date

2015-07-13

Accepted

2015-07-13 09:12:47

Documents

Effectiveness Date

2015-07-13

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	v415295_8-k.htm	DEFA14A	42290
2	EXHIBIT 2.1	v414918_ex2-1.htm	EX-2.1	622806
3	EXHIBIT 10.1	v414918_ex10-1.htm	EX-10.1	95645
4	EXHIBIT 10.2	v415295_ex10-2.htm	EX-10.2	39083
5	EXHIBIT 10.3	v414918_ex10-3.htm	EX-10.3	19690
6	GRAPHIC	line.gif	GRAPHIC	43
7	GRAPHIC	spacer.gif	GRAPHIC	43
	Complete submission text file	0001144204-15-042136.txt		821006

Mailing Address C/O MARK COHEN, CHAIRMAN, PEARL COHEN 1500 BROADWAY, 12TH FLOOR NEW YORK NY 10036

Business Address 53 DAVIES STREET LONDON X0 W1K 5JH 646-878-0804

Celsus Therapeutics Plc. (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: DEFA14A | Act: 34 | File No.: 001-36288 | Film No.: 15984819
SIC: 2834 Pharmaceutical Preparations